None listed
Conditions
Interventions
Drug :
Propofol-remifentanil is administered by target-controlled infusion during the procedure.
Their target effect-site concentrations were adjusted to maintain the sedation level between MOAAS 2-
Sponsors
Samsung Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients with the ASA PS class I~III 2) Patients scheduled for the insertion of central venous access port devices for the delivery of chemotherapy under monitored anesthetic care(MAC)
Exclusion criteria
Exclusion criteria: 1) Patients with severe cognitive dysfunction 2) Body Mass Index > 35 kg / m 2 or <18.5 kg / m 2 3) Severe liver disease 4) Neuromuscular disease or mental illness kidney disease (GRF <30 or under hemodialysis) 5) Those diagnosed with metabolic diseases 6) Drug addiction or alcohol addiction 7) People who have contraindications to benzodiazepine, sevoflurane, or propofol (Patients who have allergies to drugs or have a history of hypersensitivity reactions) 8) acute narrow-angle glaucoma 9) intolerance to galactose, deficiency of Lapp lactase, glucose-galactose absorption disorder 10) severe hypersensitivity to dextran 40
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Respiratory depression | — |
Secondary
| Measure | Time frame |
|---|---|
| Interventions due to respiratory depression;time to sedation level of MOAAS 2-3 ;time to alertness from the end of the procedure;atelectasis at PACU ;Patient's satisfaction;The operator's satisfaction;Amnesia during the procedure;apnea hypoapnea index ;Tidal volume, minute ventilation, respiratory rate | — |
Countries
Korea, Republic of
Contacts
Public ContactJeayoun Kim
Samsung Medical Center
Outcome results
None listed